Novel regions of allelic imbalance identified by genome-wide analysis of neuroblastoma

Cancer Research

Volumn 62, Issue 6, 2002, Pages 1761-1767

  Mora, Jaume ^a   Cheung, Nai Kong V ^a   Oplanich, Sandra ^a   Chen, Lishi ^a   Gerald, William L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALLELE; ALLELIC IMBALANCE; ARTICLE; CHROMOSOME 10P; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 14Q; CHROMOSOME 17Q; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 2P; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME 9P; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENOME; GENOTYPE; HUMAN; HUMAN GENOME; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL;

ALLELIC IMBALANCE; CHILD; CHILD, PRESCHOOL; FLUORESCENT DYES; GENOME, HUMAN; HUMANS; INFANT; MICROSATELLITE REPEATS; NEUROBLASTOMA;

EID: 0037086168     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Chromosomal aberrations in human neuroblastomas
2. Cytogenetic features of human neuroblastomas and cell lines
3. Human neuroblastomas and abnormalities of chromosomes 1 and 17
4. Chromosome analysis of a human neuroblastoma
5. Human neuroblastoma cytogenetics
6. Amplification of N-myc in untreated human neuroblastomas correlates with advanced stage disease
7. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas
8. Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumor-suppressor locus distal to the FHIT gene
9. Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumor suppressor gene locus
10. Loss of heterozygosity at chromosome 9p21 in primary neuroblastomas: Evidence for two deleted regions
11. Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13
12. Allelic imbalance on chromosome 5q predicts long-term survival in neuroblastoma
13. Allelic imbalance on chromosome 18 in neuroblastoma
14. Comparative genomic hybridization analysis of human neuroblastomas: Detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines
15. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization
16. Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis: Survival correlates with chromosome 17 status
17. Speleman, F Combined M-FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines
18. Allelotype of neuroblastoma
19. Revisions of the International Criteria for neuroblastoma diagnosis, staging, and response to treatment
20. Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p
21. Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma
22. Survival analysis of clinical, pathologic and genetic features in neuroblastoma presenting as local-regional disease
23. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer
24. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology
25. Preferential PCR amplification of allcles: Mechanisms and solutions
26. Allelotype of colorectal carcinomas
27. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers
28. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering
29. High resolution allelotype of microdissected primary nasopharyngeal carcinoma
30. Allelotype analysis of oesophageal adenocarcinoma: Loss of heterozygosity occurs at multiple sites
31. Identification of novel regions of allelic loss from a genome-wide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population
32. Allelotype analysis of cervical carcinoma
33. Allelotype of endometrial carcinoma
34. Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes
35. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas
36. A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer
37. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas
38. Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins
39. Microsatellite analysis of childhood brain tumors
40. Allelotype analysis of childhood acute lymphoblastic leukemia
41. High-resolution allelotype analysis of childhood B-lineage acute lymphoblastic leukemia
42. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
43. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
44. Molecular analysis of chromosome arm 17q gain in neuroblastoma
45. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.2
46. Comparative genomic hybridization and its application to Wilms’ tumorigenesis
47. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome
48. Genetic analysis of ovarian germ cell tumors by comparative genomic hybridization
49. Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms
50. The chromosome 10 monosomy common in human melanomas results from loss of two separate tumor suppressor loci
51. Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas
52. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
53. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours
54. A novel gene, LGII, from 10q24 is rearranged and downregulated in malignant brain tumors
55. The human ribosomal protein L6 gene in a critical region for Noonan syndrome
56. Chromosomal localization, genomic characterization, and mapping to the Noonan syndrome critical region of the human Deltex (DTXI) gene
57. Isolation and chromosomal assignment of a novel human gene, CORO1C, homologous to coronin-like actin-binding proteins
58. Mosaicism of unstable CAG repeats in the brain of spinocerebellar ataxia type 2
59. The structural basis of phenylketonuria
60. Neuroblastoma: Effect of genetic factors on prognosis and treatment
61. N7: A novel multi-modality therapy of high risk neuroblastoma in children diagnosed over 1 year of age
62. Survival from non-stage 4 neuroblastoma without cytotoxic therapy: An analysis of clinical and biological markers
63. Monoclonal antibody-based therapy of neuroblastoma